David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Laugh If You Want, but This Trash Deal Is a Coup for Nikola Stock

By David Moadel, InvestorPlace Contributor

Waste management and electric vehicles are both big business. What do you get when you combine the two? A great reason to own Nikola stock.

Marathon Patent Group Is a Decent but Imperfect Bitcoin Price Proxy

By David Moadel, InvestorPlace Contributor

Investors shouldn't even consider buying MARA stock unless they're bullish, or at least neutral, on the future price of Bitcoin.

For Fun and Profits, Take a Chance and Try Arcimoto

By David Moadel, InvestorPlace Contributor

Ready to take a chance on a truly unique electric vehicle company? Dare to try something different with a position in Arcimoto stock.

Hold Eli Lilly as Mobile Covid-19 Labs Address Critical Needs

By David Moadel, InvestorPlace Contributor

Some folks consider LLY stock a dull investment, but don't forget that Eli Lilly could play a pivotal role in the battle against Covid-19.

Abbott Laboratories Is a Surefire Covid-19 Diagnostics Investment

By David Moadel, InvestorPlace Contributor

Don't hesitate to buy ABT stock as vast quantities of Covid-19 test shipments indicate robust business for Abbott Laboratories.

Load More